Michael Yurkowsky
Vorstandsvorsitzender bei INNOVEREN SCIENTIFIC INC.
Vermögen: 306 $ am 31.03.2024
Aktive Positionen von Michael Yurkowsky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNOVEREN SCIENTIFIC INC. | Direktor/Vorstandsmitglied | 08.01.2019 | - |
| Vorstandsvorsitzender | 06.12.2021 | - | |
| Independent Dir/Board Member | - | - | |
| YP Holdings LLC (Florida) | Corporate Officer/Principal | - | - |
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Vorstandsvorsitzender | - | - |
| Gründer | - | - | |
| Präsident | - | - | |
| Immuni-T, Inc. | Vorstandsvorsitzender | - | - |
Jantibody LLC
 Jantibody LLC Pharmaceuticals: MajorHealth Technology Part of Innoveren Scientific, Inc., Jantibody LLC is a company that provides cancer treatment drugs. The company is based in St. Augustine, FL. Jantibody was acquired by Innoveren Scientific, Inc. on September 08, 2022 for $0.23 million. | Präsident | - | - |
Karriereverlauf von Michael Yurkowsky
Ehemalige bekannte Positionen von Michael Yurkowsky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 21.05.2019 | 22.09.2022 |
Wachovia Securities LLC
 Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Corporate Officer/Principal | 01.08.2003 | 01.08.2003 |
| Trenchant Asset Management Ltd. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
Sektoral
| Health Technology | 5 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INNOVEREN SCIENTIFIC INC. | Health Technology |
| VICAPSYS LIFE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Wachovia Securities LLC
Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Finance |
| YP Holdings LLC (Florida) | |
| Trenchant Asset Management Ltd. | |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
| Immuni-T, Inc. | |
Jantibody LLC
Jantibody LLC Pharmaceuticals: MajorHealth Technology Part of Innoveren Scientific, Inc., Jantibody LLC is a company that provides cancer treatment drugs. The company is based in St. Augustine, FL. Jantibody was acquired by Innoveren Scientific, Inc. on September 08, 2022 for $0.23 million. | Health Technology |
- Börse
- Insiders
- Michael Yurkowsky
- Erfahrung
